GL1X · GenesisL1 explorer

Research workbench

Beta variant SARS-cov-2 spike with 2 erect rbds

Analyse Beta variant SARS-cov-2 spike with 2 erect rbds in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7R17
Type
protein
Length
2,981 residues
Chains
3
Method
electron microscopy
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Spike glycoprotein
UniProt
P0DTC2
Ligands
NAG
Pockets
20 · best druggability 0.87

Structure

electron microscopy · 3 distinct chains · 21% helix, 30% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASpike glycoproteinprotein99421% helix, 29% strandP0DTC2
BSpike glycoproteinprotein100020% helix, 29% strandP0DTC2
CSpike glycoproteinprotein98721% helix, 32% strandP0DTC2

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 22 copies · chains A, C, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

20 pockets found on a 1 Å grid, 20 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
110700.870.88123empty
210200.830.84105empty
36660.800.8459empty
41470.790.9428empty
512000.790.81103empty

Interfaces

3 interfaces between chains.

  • A–C · 4736 Ų buried · 45 hydrogen bonds · protein-protein
  • B–C · 4122 Ų buried · 24 hydrogen bonds · protein-protein
  • A–B · 4118 Ų buried · 28 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 38 disulfide, 21 glycan (disulfide, N-glycosylation).

Compared structures

  • 7R17 · Beta Variant SARS-CoV-2 Spike with 2 Erect RBDs · the same entry in another collection · chain C against C, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.